<DOC>
	<DOCNO>NCT00116324</DOCNO>
	<brief_summary>The purpose study examine specific variation genetic code enzyme ( LTC4 synthase ) play important role airway inflammation associate asthma . We hypothesize asthmatic patient variant gene well response montelukast patient wild type gene , measure ability montelukast protect hypertonic saline challenge .</brief_summary>
	<brief_title>Predicting Response Montelukast Genetic Variation Asthmatics</brief_title>
	<detailed_description>Multiple genetic polymorphism leukotriene pathway describe clinical relevance unclear . A single nucleotide polymorphism LTC4 synthase promoter region associate increase LTC4 synthase mRNA trend toward improved bronchodilatory response leukotriene modifier severe asthmatic . This study examine mild moderate asthmatic variant gene evaluate bronchoprotective response montelukast double-blind , placebo-controlled cross-over fashion .</detailed_description>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Male female subject , age 1855 Clinical history consistent asthma Mild moderate asthma determine pulmonary function tests60 % high predict FEV1 age , sex race . Response hypertonic saline , main outcome variable measure . Smokers ( total lifetime smoke history &gt; 10 packyears , past year ) Pregnant womanâ€”if childbearing age , use acceptable form birth control . Use leukotriene modifier within past month Use inhale oral steroid within past month . Emergency room visit asthma exacerbation within past 6 week . Intubation asthma exacerbation past 10 year . Adverse reaction inhale betaagonists past . No recent ( past 48 hour ) use anticholinergic , theophylline , antihistamine , pseudoephedrine . Patients also ask use short act betaagonists 6 hour longacting betaagonists 48 hour initial visit ( pulmonary function evaluation perform ) . Lung disease asthma Significant medical illness asthma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Leukotriene receptor antagonist</keyword>
	<keyword>Hypertonic saline challenge</keyword>
</DOC>